Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP)-Reference-Cited by-同舟云学术

Evidence of Misclassification of Drug–Event Associations Classified as Gold Standard ‘Negative Controls’ by the Observational Medical Outcomes Partnership (OMOP)

Published:2016-02-15 Issue:5 Volume:39 Page:421-432
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Hauben Manfred,Aronson Jeffrey K.,Ferner Robin E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-016-0392-2.pdf

Reference104 articles.

1. Hauben M, Norén GN. A decade of data mining and still counting. Drug Saf. 2010;33(7):527–34.

2. Observational Medical Outcomes Partnership (OMOP). http://fnih.org/what-we-do/major-completed-programs/omop . Accessed 21 Jan 2016.

3. Observational Medical Outcomes Partnership. http://omop.org . Accessed 21 Jan 2016.

4. Cardoso JR, Pereira LM, Iversen MD, Ramos AL. What is gold standard and what is ground truth? Dental Press J Orthod. 2014;19(5):27–30.

5. Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Empirical assessment of methods for risk identification in healthcare data: results from experiments of the Observational Medical Outcomes Partnership. Stat Med. 2012;31(30):4401–15.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for practical use of tree-based scan statistics for signal detection using electronic healthcare data: a case study with insulin glargine;Expert Opinion on Drug Safety;2024-08-23

2. A real-world pharmacovigilance study on cardiovascular adverse events of tisagenlecleucel using machine learning approach;Scientific Reports;2024-06-13

3. Testing an informatics consulting service for systematic bias using negative control reference sets;2024-01-11

4. Implementation of a Taxonomy-Based Framework for the Selection of Appropriate Drugs and Outcomes for Real-World Data Signal Detection Studies;Drug Safety;2023-12-13

5. Response to the comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions;Pharmacoepidemiology and Drug Safety;2023-11-27